Overview
Availability
- Dr Robert Ju is:
- Available for supervision
Qualifications
- Bachelor of Biomedical Science, Queensland University of Technology
- Bachelor (Honours) of Biomedical Science, Queensland University of Technology
- Doctoral (Research) of Cell Biology, The University of Queensland
Works
Search Professor Robert Ju’s works on UQ eSpace
2019
Conference Publication
Bortezomib induces immunogenic cell death in melanoma and enhances immune responses in vivo
Daignault, S. M., Ju, R. J., Spoerri, L., Stehbens, S. J., Dolcetti, R. and Haass, N. K. (2019). Bortezomib induces immunogenic cell death in melanoma and enhances immune responses in vivo. 49th Annual Meeting of the European Society for Dermatological Research (ESDR), Bordeaux, France, 18-21 September, 2019. Oxford, United Kingdom: Elsevier. doi: 10.1016/j.jid.2019.07.506
2018
Journal Article
Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer
Packer, Leisl M., Stehbens, Samantha J., Bonazzi, Vanessa F., Gunter, Jennifer H., Ju, Robert J., Ward, Micheal, Gartside, Michael G., Byron, Sara A. and Pollock, Pamela M. (2018). Bcl-2 inhibitors enhance FGFR inhibitor-induced mitochondrial-dependent cell death in FGFR2-mutant endometrial cancer. Molecular Oncology, 13 (4), 738-756. doi: 10.1002/1878-0261.12422
2018
Journal Article
The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis
Ju, Robert J., Stehbens, Samantha J. and Haass, Nikolas K. (2018). The role of melanoma cell-stroma interaction in cell motility, invasion, and metastasis. Frontiers in Medicine, 5 (NOV) 307, 1-9. doi: 10.3389/fmed.2018.00307
2018
Journal Article
FGFR2b activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer
Stehbens, Samantha J., Ju, Robert J., Adams, Mark N., Perry, Samuel, Haass, Nikolas K., Bryant, David M. and Pollock, Pamela M. (2018). FGFR2b activating mutations disrupt cell polarity to potentiate migration and invasion in endometrial cancer. Journal of Cell Science, 131 (15) jcs.213678, 1-16. doi: 10.1242/jcs.213678
2017
Journal Article
PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2mutant endometrial cancers
Packer, Leisl M., Geng, Xinyan, Bonazzi, Vanessa F., Ju, Robert J., Mahon, Clare E., Cummings, Margaret C., Stephenson, Sally-Anne and Pollock, Pamela M. (2017). PI3K inhibitors synergize with FGFR inhibitors to enhance antitumor responses in FGFR2mutant endometrial cancers. Molecular Cancer Therapeutics, 16 (4), 637-648. doi: 10.1158/1535-7163.MCT-16-0415
Funding
Current funding
Supervision
Availability
- Dr Robert Ju is:
- Available for supervision
Before you email them, read our advice on how to contact a supervisor.
Supervision history
Current supervision
-
Doctor Philosophy
Understanding the role of microtubules in mitochondrial positioning and function during cell migration
Associate Advisor
Other advisors: Dr Julia Pagan, Dr Samantha Stehbens
Media
Enquiries
For media enquiries about Dr Robert Ju's areas of expertise, story ideas and help finding experts, contact our Media team: